CRSPN Analyst Ratings
Moderate Buy
10 Buy
6 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CRSPN Stock 12 Month Forecast
Average Price Target
$1,265.01
▲(55.97% Upside)
| Highest Price Target$1,918 | Average Price Target$1,265 | Lowest Price Target$784.82 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Citizens JMP
$1,395.24
Buy
72.02%
Upside
Reiterated
07/22/26
H.C. Wainwright
$1,395.24
Buy
72.02%
Upside
Reiterated
07/08/26
Bank of America Securities
$1,447.56
Buy
78.47%
Upside
Reiterated
07/07/26
Piper Sandler
$1,918.45
Buy
136.53%
Upside
Reiterated
07/02/26
Needham
$1,430.12
Buy
76.32%
Upside
Reiterated
06/24/26
Morgan Stanley
$1,046.43
Hold
29.02%
Upside
Upgraded
06/11/26
William Blair
―
Buy
―
Reiterated
06/04/26
Bernstein
$872.02→$976.66
Hold
20.42%
Upside
Assigned
05/13/26
Evercore ISI
$1,290.59→$1,325.47
Buy
63.42%
Upside
Reiterated
05/11/26
Citi
$1,395.24→$1,430.12
Buy
76.32%
Upside
Assigned
05/06/26
Wells Fargo
$1,308.03
Hold
61.27%
Upside
Reiterated
05/05/26
TD Cowen
$784.82
Hold
-3.24%
Downside
Reiterated
05/04/26
Chardan Capital
$1,325.47
Buy
63.42%
Upside
Reiterated
05/04/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Citizens JMP
$1,395.24
Buy
72.02%
Upside
Reiterated
07/22/26
H.C. Wainwright
$1,395.24
Buy
72.02%
Upside
Reiterated
07/08/26
Bank of America Securities
$1,447.56
Buy
78.47%
Upside
Reiterated
07/07/26
Piper Sandler
$1,918.45
Buy
136.53%
Upside
Reiterated
07/02/26
Needham
$1,430.12
Buy
76.32%
Upside
Reiterated
06/24/26
Morgan Stanley
$1,046.43
Hold
29.02%
Upside
Upgraded
06/11/26
William Blair
―
Buy
―
Reiterated
06/04/26
Bernstein
$872.02→$976.66
Hold
20.42%
Upside
Assigned
05/13/26
Evercore ISI
$1,290.59→$1,325.47
Buy
63.42%
Upside
Reiterated
05/11/26
Citi
$1,395.24→$1,430.12
Buy
76.32%
Upside
Assigned
05/06/26
Wells Fargo
$1,308.03
Hold
61.27%
Upside
Reiterated
05/05/26
TD Cowen
$784.82
Hold
-3.24%
Downside
Reiterated
05/04/26
Chardan Capital
$1,325.47
Buy
63.42%
Upside
Reiterated
05/04/26
Best Analysts Covering Crispr Therapeutics AG
3 Months
Success Rate
13/22 ratings generated profit
Average Return
+7.56%
Copying Mani Foroohar's trades and holding each position for 3 Months would result in 59.09% of your transactions generating a profit, with an average return of +7.56% per trade.
1 Year
Success Rate
11/22 ratings generated profit
Average Return
+6.56%
Copying Mani Foroohar's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +6.56% per trade.
2 Years
Success Rate
7/17 ratings generated profit
Average Return
-5.40%
Copying Kostas Biliouris's trades and holding each position for 2 Years would result in 41.18% of your transactions generating a profit, with an average return of -5.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CRSPN Analyst Recommendation Trends
Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
12
9
9
9
9
Buy
7
6
6
6
7
Hold
6
3
5
5
6
Sell
1
1
0
0
0
Strong Sell
0
0
0
0
0
total
26
19
20
20
22
Each month's total comprises the sum of three months' worth of ratings.
CRSPN Financial Forecast
CRSPN Stock Forecast FAQ
What is MX:CRSPN’s average 12-month price target, according to analysts?
Based on analyst ratings, Crispr Therapeutics AG’s 12-month average price target is 1,265.01.
What is MX:CRSPN’s upside potential, based on the analysts’ average price target?
Crispr Therapeutics AG has 55.97% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Crispr Therapeutics AG a Buy, Sell or Hold?
Crispr Therapeutics AG has a consensus rating of Moderate Buy, which is based on 10 buy ratings, 6 hold ratings and 0 sell ratings.
What is Crispr Therapeutics AG’s share price target?
The average share price target for Crispr Therapeutics AG is 1,265.01. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $1,918.45 ,and the lowest forecast is $784.82. The average share price target represents 55.97% Increase from the current price of $811.08.
The highest analyst share price target is $1,918.45 ,and the lowest forecast is $784.82. The average share price target represents 55.97% Increase from the current price of $811.08.
What do analysts say about Crispr Therapeutics AG?
Crispr Therapeutics AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 16 Wall Streets Analysts.
How can I buy shares of Crispr Therapeutics AG?
To buy shares of MX:CRSPN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.